Home > Press > Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant
Nanomix Inc., a leading nanoelectronic detection company commercializing high-value diagnostic and monitoring applications, today announced that it has been awarded a follow-on $500,000 National Science Foundation (NSF) Phase IIB grant. This grant, in addition to the previous grants awarded in 2003 & 2005, brings the total NSF funding awarded to Nanomix for this project to over $1,100,000.
Nanomix Announces Award of $500K National Science Foundation Phase IIB Grant
EMERYVILLE, CA | Posted on February 21st, 2007
The grant award will be used to continue the development and commercialization of Nanomix' Sensation™ nanoelectronic detection platform, through partnership with academia and industry. The platform is the basis for detection applications in the biomolecule, respiratory, and agricultural fields. NSF awards are earned through a peer-reviewed competition, with innovation, educational value and potential economic benefits as criteria.
David Macdonald, Nanomix CEO, said, "We are honored to receive another grant from the National Science Foundation. It further validates the value of our technology and will enable additional progress toward our commercialization goals."
Principal Investigator Dr. Jean-Christophe Gabriel added, "Further development of our nanotube based platform will support our commercialization efforts for multiple applications, all of which offer the critical advantages that we bring to the field of detection: high performance with cost-effective, scalable manufacturing, provided in a small form factor. Random network carbon nanotube field-effect transistors have excellent operating characteristics. The market potential is impressive."
Nanomix is a leading nanoelectronic detection company launching a portfolio of devices based on Sensation™ technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across a broad range of industrial and medical applications where valuable attributes - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California.
For more information, please click here
Bill Perry, 510-428-5300
Vice President of Sales, Marketing
and Business Development
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014
A*STAR and industry form S$200M semiconductor R&D July 25th, 2014
A Crystal Wedding in the Nanocosmos July 23rd, 2014
3-D nanostructure could benefit nanoelectronics, gas storage: Rice U. researchers predict functional advantages of 3-D boron nitride July 15th, 2014
IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems: Scientists and engineers to push limits of silicon technology to 7 nanometers and below and create post-silicon future July 10th, 2014
Industrial Nanotech, Inc. to Publish PCAOB Audited Financials July 31st, 2014
Nanostructured metal-oxide catalyst efficiently converts CO2 to methanol: Highly reactive sites at interface of 2 nanoscale components could help overcome hurdle of using CO2 as a starting point in producing useful products July 31st, 2014
Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014
Pressure probing potential photoelectronic manufacturing compound July 31st, 2014
New imaging agent provides better picture of the gut July 25th, 2014
Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014